Investor · Durham, NC
Myla V. Lai-Goldman
Open Myla in the network graph →Filings
20
SEC Form D
Connections
135
co-filers
Capital
$5.7M
across filings
Active
Feb 2020
to May 2022
Most-connected co-filers (135)
Michael V. Milburn · Durham, NC11 sharedClay Thorp · Malvern, PA11 sharedArnold V. Levine · Durham, NC9 sharedCharles Perou · Durham, NC8 sharedEllen Lubman · Morristown, NJ6 sharedJohn Novak · HIghtstown, NJ5 sharedAugustin Duhamel · LONDON, United Kingdom5 sharedPierre-Antoine De Selancy · LONDON, United Kingdom5 sharedDavid P. Smilow · New York, NY5 sharedGregory Makkay · HIghtstown, NJ5 sharedMarc Michel · HIghtstown, NJ5 sharedOliver Pritchard · London, United Kingdom5 sharedTom War · West Linn, OR4 shared17 Capital LLP · London, United Kingdom3 sharedJason Steinberg · HIghtstown, NJ3 shared17Capital Fund 5 Luxembourg GP s.a r.l · Munsbach, Luxembourg3 sharedRobert De Corainville · New York, NY3 shared17 Capital LLP · London, United Kingdom3 sharedAnne Marie W. Bernard · Boston, MA2 sharedRobertson G. Mansi · Boston, MA2 sharedJohn M. Corcoran · Boston, MA2 sharedCharuda G. Upatham-Costello · Boston, MA2 sharedMichael W. Roberge · Boston, MA2 sharedEric Chapman · HIghtstown, NJ2 shared
Recent filings (20)
GeneCentric Therapeutics, Inc.Jun 2025 · 18 co-filers$5.0MGeneCentric Therapeutics, Inc.Sep 2022 · 16 co-filers$3.5M17Capital Credit Partners Fund USD Feeder SCSpMay 2022 · 19 co-filers17Capital Credit Fund EUR SCSpNov 2021 · 19 co-filersGeneCentric Therapeutics, Inc.Oct 2021 · 16 co-filers$7.5M17Capital Fund 5 USD SCSpJul 2021 · 17 co-filersPRIMUS CAPITAL FUND IX, LPMay 2021 · 17 co-filers$750.0MPRIMUS CAPITAL FUND IX-A, LPMay 2021 · 17 co-filers$750.0MMFS Emerging Markets Debt LLC IMay 2021 · 22 co-filersMFS Global Aggregate Opportunistic LLCApr 2021 · 22 co-filersGeneCentric Therapeutics, Inc.Jan 2021 · 16 co-filers$1.2M17Capital Fund 5 USD SCSpAug 2020 · 18 co-filers17Capital Fund 5 USDC SCSpFeb 2020 · 18 co-filersSVXR, Inc.Feb 2020 · 2 co-filers$6.0MSVXR, Inc.Feb 2020 · 2 co-filers$6.0MGeneCentric Diagnostics, Inc.Jan 2017 · 14 co-filers$8.6MSEQUENOM INCJun 2015 · 34 co-filers$85.0MGeneCentric Diagnostics, Inc.Sep 2011 · 2 co-filers$250KCancerGuide Diagnostics, Inc.Mar 2010 · 9 co-filers$10.5MCancerGuide Diagnostics, Inc.Jan 2010 · 9 co-filers$10.5M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Myla in the interactive graph →